Indication
Treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
Medicine details
- Medicine name:
- daridorexant (Quviviq)
- SMC ID:
- SMC2611
- Pharmaceutical company
- Idorsia Pharmaceuticals UK Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC